The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The chemotherapeutic agent topotecan differentially modulates the phenotype and function of dendritic cells

Published:2013-05-11 Issue:8 Volume:62 Page:1315-1326
ISSN:0340-7004
Container-title:Cancer Immunology, Immunotherapy
language:en
Short-container-title:Cancer Immunol Immunother

Author:

Trojandt Stefanie,Knies Diana,Pektor Stefanie,Ritz Sandra,Mailänder Volker,Grabbe Stephan,Reske-Kunz Angelika B.,Bros Matthias

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1007/s00262-013-1431-9.pdf

Reference50 articles.

1. Alagoz M, Gilbert DC, El-Khamisy S, Chalmers AJ (2012) DNA repair and resistance to topoisomerase I inhibitors: mechanisms, biomarkers and therapeutic targets. Curr Med Chem 19:3874–3885

2. Kollmannsberger C, Mross K, Jakob A, Kanz L, Bokemeyer C (1999) Topotecan-A novel topoisomerase I inhibitor: pharmacology and clinical experience. Oncology 56:1–12

3. Aoki D, Katsumata N, Nakanishi T, Kigawa J, Fujiwara K, Takehara K et al (2011) A phase II clinical trial of topotecan in Japanese patients with relapsed ovarian carcinoma. Jpn J Clin Oncol 41:320–327

4. Suzuki H, Hirashima T, Kobayashi M, Sasada S, Okamoto N, Uehara N et al (2011) Effect of topotecan as second-line chemotherapy for small cell lung cancer patients with interstitial lung disease. J Chemother 23:367–370

5. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3:721–732

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy;Cancer Immunology, Immunotherapy;2024-04-02

2. Activation of STING by the Novel Liposomal TLC388 Enhances the Therapeutic Response to Anti-PD-1 Antibodies in Combination with Radiotherapy;2024-01-30

3. Delayed vaccine-induced CD8⁺T cell expansion by topoisomerase I inhibition mediates enhanced CD70-dependent tumor eradication;Journal for ImmunoTherapy of Cancer;2023-11

4. The druggable transcription factor Fli-1 regulates T cell immunity and tolerance in graft-versus-host disease;Journal of Clinical Investigation;2022-11-01

5. Inhibition of topoisomerase I shapes antitumor immunity through the induction of monocyte-derived dendritic cells;Cancer Letters;2021-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3